Tottori, Japan

Masao Miyagawa



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masao Miyagawa: Innovator in Medicinal Chemistry

Introduction

Masao Miyagawa is a prominent inventor based in Tottori, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents for diabetes complications and dysuria. With a total of 2 patents, his work has the potential to improve the quality of life for many patients suffering from these conditions.

Latest Patents

Miyagawa's latest patents include innovative uses of cyclohexenone derivatives. The first patent focuses on the use of these derivatives in the manufacture of a medicament for treating diabetic complications. This preventive and/or therapeutic agent significantly suppresses a reduction in peripheral nerve conduction rate and alleviates bladder hypofunction, making it particularly useful for diabetic neuropathy. The second patent addresses dysuria, offering a preventive and/or therapeutic agent that alleviates this condition due to urinary bladder hypofunction.

Career Highlights

Miyagawa is currently associated with Meiji Dairies Corporation, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential applications in treating common yet challenging health issues.

Collaborations

Miyagawa has collaborated with notable colleagues, including Takeshi Watanabe and Motoaki Saito. Their combined expertise has contributed to the successful development of innovative therapeutic solutions.

Conclusion

Masao Miyagawa's contributions to medicinal chemistry highlight the importance of innovation in addressing health challenges. His patents reflect a commitment to improving patient care through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…